An evidence-based narrative review of the emergency department evaluation and management of rhabdomyolysis

Published:January 02, 2019DOI:https://doi.org/10.1016/j.ajem.2018.12.061

      Abstract

      Background

      Rhabdomyolysis is a medical condition caused by muscle breakdown leading to potential renal damage. This can result in significant morbidity and mortality if not rapidly identified and treated.

      Objective

      This article provides an evidence-based narrative review of the diagnosis and management of rhabdomyolysis, with focused updates for the emergency clinician.

      Discussion

      Rhabdomyolysis is caused by the breakdown of muscle cells leading to the release of numerous intracellular molecules, including potassium, calcium, phosphate, uric acid, and creatinine kinase. There are a number of potential etiologies, including exertion, extreme temperature changes, ischemia, infections, immobility, drugs, toxins, endocrine causes, autoimmune reactions, trauma, or genetic conditions. Findings can include myalgias, muscle weakness, or dark-colored urine, but more often include non-specific symptoms. The diagnosis is often determined with an elevated creatinine kinase greater than five times the upper-limit of normal. Severe disease may result in renal failure, electrolyte derangements, liver disease, compartment syndrome, and disseminated intravascular coagulation. Treatment includes addressing the underlying etiology, as well as aggressive intravenous hydration with a goal urine output of 300 mL/h. Bicarbonate, mannitol, and loop diuretics do not possess strong evidence for improved outcomes. Renal replacement therapy should be determined on a case-by-case basis. Most patients are admitted, though some may be appropriate for discharge.

      Conclusion

      Rhabdomyolysis is a potentially dangerous medical condition requiring rapid diagnosis and management that may result in significant complications if not appropriately identified and treated. Emergency clinician knowledge of this condition is essential for appropriate management.

      Keywords

      To read this article in full you will need to make a payment

      References

        • Zutt R.
        • van der Kooi A.J.
        • Linthorst G.E.
        • et al.
        Rhabdomyolysis: review of the literature.
        Neuromuscul Disord. 2014; 24: 651-659
        • Torres P.A.
        • Helmstetter J.A.
        • Kaye A.M.
        Rhabdomyolysis. Pathogenesis, diagnosis, and treatment.
        Oschner J. 2015; 15: 58-69
        • Huerta-Alardin A.L.
        • Varon J.
        • Marik P.E.
        Bench-to-bedside review: rhabdomyolysis – an overview for clinicians.
        Crit Care. 2005; 9: 158-169
        • Cervellin G.
        • Comelli I.
        • Lippi G.
        Rhabdomyolysis: historical background, clinical, diagnostic and therapeutic features.
        Clin Chem Lab Med. 2010 Jun; 48: 749-756
        • Kruger D.
        • Han J.
        Assessing acquired rhabdomyolysis in adults.
        JAAPA. 2017; 30: 20-26
        • Keltz E.
        • Khan F.Y.
        • Mann G.
        Rhabdomyolysis. The role of diagnostic and prognostic factors.
        Muscles Ligaments Tendons J. 2014; 3: 303-312
        • Sauret J.M.
        • Marinides G.
        • Wang G.K.
        Rhabdomyolysis.
        Am Fam Physician. 2002; 65: 907-912
        • Lane R.
        • Phillips M.
        Rhabdomyolysis.
        BMJ. 2003; 327: 115-116
        • Antons K.A.
        • Williams C.D.
        • Baker S.K.
        • Phillips P.S.
        Clinical perspectives of statin-induced rhabdomyolysis.
        Am J Med. 2006; 119: 400-409
        • Pasternak R.C.
        • Smith Jr., S.C.
        • Bairey-Merz C.N.
        • et al.
        ACC/AHA/NHLBI clinical advisory on the use and safety of statins.
        Stroke. 2002; 33: 2337-2341
        • Chavez L.O.
        • Leon M.
        • Einav S.
        Beyond muscle destruction: a systematic review of rhabdomyolysis for clinical practice.
        Crit Care. 2016; 20: 135
        • Bosch X.
        • Poch E.
        • Grau J.M.
        Rhabdomyolysis and acute kidney injury.
        N Engl J Med. 2009; 361: 62-72
        • Brown C.V.
        • Rhee P.
        • Chan L.
        • et al.
        Preventing renal failure in patients with rhabdomyolysis: do bicarbonate and mannitol make a difference?.
        J Trauma. 2004; 56: 1191-1196
        • Veenstra J.
        • Smit W.M.
        • Krediet R.T.
        • Arisz L.
        Relationship between elevated creatine phosphokinase and the clinical spectrum of rhabdomyolysis.
        Nephrol Dial Transpl. 1994; 9: 637-641
        • Alpers J.P.
        • Jones Jr., L.K.
        Natural history of exertional rhabdomyolysis: a population-based analysis.
        Muscle Nerve. 2010; 42: 487-491
        • Chamberlain M.C.
        Rhabdomyolysis in children: a 3-year retrospective study.
        Pediatr Neurol. 1991; 7: 226-228
        • Chakravartty S.
        • Sarma D.R.
        • Patel A.G.
        Rhabdomyolysis in bariatric surgery: a systematic review.
        Obes Surg. 2013; 23: 1333-1340
        • Iwere R.B.
        • Hewitt J.
        Myopathy in older people receiving statin therapy: a systematic review and meta-analysis.
        Br J Clin Pharmacol. 2015; 80: 363-371
        • Perreault S.
        • Birca A.
        • Piper D.
        • et al.
        Transient creatine phosphokinase elevations in children: a single-center experience.
        J Pediatr. 2011; 159: 682-685
        • Mackay M.T.
        • Kornberg A.J.
        • Shield L.K.
        • Dennett X.
        Benign acute childhood myositis: laboratory and clinical features.
        Neurology. 1999; 53: 2127-2131
        • Adams E.C.
        Differentiation of myoglobin and hemoglobin in biological fluids.
        Ann Clin Lab Sci. 1980; 10: 493-499
        • Petejova N.
        • Martinek A.
        Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review.
        Crit Care. 2014; 18: 224
        • Knochel J.P.
        Mechanisms of rhabdomyolysis.
        Curr Opin Rheumatol. 1993; 5: 725-731
        • Zager R.A.
        Rhabdomyolysis and myohemoglobinuric acute renal failure.
        Kidney Int. 1996; 49: 314-326
        • Al-Ismaili Z.
        • Piccioni M.
        • Zappitelli M.
        Rhabdomyolysis: pathogenesis of renal injury and management.
        Pediatr Nephrol. 2011 Oct; 26: 1781-1788
        • Luck R.P.
        • Verbin S.
        Rhabdomyolysis: a review of clinical presentation, etiology, diagnosis, and management.
        Pediatr Emerg Care. 2008; 24: 262-268
        • Shapiro M.L.
        • Baldea A.
        • Luchette F.A.
        Rhabdomyolysis in the intensive care unit.
        J Intensive Care Med. 2012; 27: 335-342
        • Brancaccio P.
        • Lippi G.
        • Maffulli N.
        Biochemical markers of muscular damage.
        Clin Chem Lab Med. 2010; 48: 757-767
        • Hendgen-Cotta U.B.
        • Flögel U.
        • Kelm M.
        • Rassaf T.
        Unmasking the Janus face of myoglobin in health and disease.
        J Exp Biol. 2010; 213: 2734-2740
        • Plotnikov E.Y.
        • Chupyrkina A.A.
        • Pevzner I.B.
        • et al.
        Myoglobin causes oxidative stress, increase of NO production and dysfunction of kidney's mitochondria.
        Biochim Biophys Acta. 2009; 1792: 796-803
        • Gabow P.A.
        • Kaehny W.D.
        • Kelleher S.P.
        The spectrum of rhabdomyolysis.
        Medicine (Baltimore). 1982; 61: 141-152
        • Holt S.G.
        • Moore K.P.
        Pathogenesis and treatment of renal dysfunction in rhabdomyolysis.
        Intensive Care Med. 2001; 27: 803-811
        • Holt S.
        • Moore K.
        Pathogenesis of renal failure in rhabdomyolysis: the role of myoglobin.
        Exp Nephrol. 2000; 8: 72-76
        • Warren J.D.
        • Blumbergs P.C.
        • Thompson P.D.
        Rhabdomyolysis: a review.
        Muscle Nerve. 2002; 25: 332-347
        • Mannix R.
        • Tan M.L.
        • Wright R.
        • Baskin M.
        Acute pediatric rhabdomyolysis: causes and rates of renal failure.
        Pediatrics. 2006; 118: 2119-2125
        • Melli G.
        • Chaudhry V.
        • Cornblath D.R.
        Rhabdomyolysis: an evaluation of 475 hospitalized patients.
        Medicine (Baltimore). 2005; 84: 377-385
        • Zutt R.
        • van der Kooi A.J.
        • Linthorst G.E.
        • et al.
        Recurrent rhabdomyolysis: screening for underlying disease.
        Ned Tijdschr Geneeskd. 2010; 154: A2290
        • Nelson D.A.
        • Deuster P.A.
        • Carter R.
        • et al.
        Sickle cell trait, rhabdomyolysis, and mortality among U.S. army soldiers.
        NEJM. 2016; 375: 435-442
        • Lahoria R.
        • Milone M.
        Rhabdomyolysis featuring muscular dystrophies.
        J Neurol Sci. 2016; 361: 29-33
        • Hilton-Jones D.
        Statin-related myopathies.
        Pract Neurol. 2018; 18: 97-105
        • Nguyen K.A.
        • Li L.
        • Lu D.
        • et al.
        A comprehensive review and meta-analysis of risk factors for statin-induced myopathy.
        Eur J Clin Pharmacol. 2018; https://doi.org/10.1007/s00228-018-2482-9
        • Tietze D.C.
        • Borchers J.
        Exertional rhabdomyolysis in the athlete: a clinical review.
        Sports Health. 2014; 6: 336-339
        • Rawson E.S.
        • Clarkson P.M.
        • Tarnapolsky M.A.
        Perspectives on exertional rhabdomyolysis.
        Sports Med. 2017; 47: S33-S49
        • Duncan S.J.
        • Howden C.W.
        Proton pump inhibitors and risk of rhabdomyolysis.
        Drug Saf. 2017; 40: 61-64
        • Yang W.X.
        • Fan K.L.
        • Leung L.P.
        A cluster of patients with rhabdomyolysis after eating crayfish.
        CJEM. 2017 Sep; 12 ([Epub ahead of print]): 1-3https://doi.org/10.1017/cem.2017.391
        • Diaz J.H.
        Global incidence of rhabdomyolysis after cooked seafood consumption (Haff disease).
        Clin Toxicol (Phila). 2015 Jun; 53: 421-426
        • Donaldson J.
        • Haddad B.
        • Khan W.S.
        The pathophysiology, diagnosis and current management of acute compartment syndrome.
        Open Orthop J. 2014 Jun 27; 8: 185-193
        • Montague B.T.
        • Ouellette J.R.
        • Buller G.K.
        Retrospective review of the frequency of ECG changes in hyperkalemia.
        Clin J Am Soc Nephrol. 2008; 3: 324-330
        • Chatzizisis Y.S.
        • Misirli G.
        • Hatzitolios A.I.
        • Giannoglou G.D.
        The syndrome of rhabdomyolysis: complications and treatment.
        Eur J Intern Med. 2008; 19: 568-574
        • Russell T.A.
        Acute renal failure related to rhabdomyolysis: pathophysiology, diagnosis, and collaborative management.
        Nephrol Nurs J. 2000; 27 ([quiz 576-7]): 567-575
        • Zimmerman J.L.
        • Shen M.C.
        Rhabdomyolysis.
        Chest. 2013; 144: 1058-1065
        • Zager R.A.
        Studies of mechanisms and protective maneuvers in myoglobinuric acute renal injury.
        Lab Invest. 1989; 60: 619-629
        • Ward M.M.
        Factors predictive of acute renal failure in rhabdomyolysis.
        Arch Intern Med. 1988; 148: 1553-1557
        • Akmal M.
        • Massry S.G.
        Reversible hepatic dysfunction associated with rhabdomyolysis.
        Am J Nephrol. 1990; 10: 49-52
        • Better O.S.
        • Abassi Z.A.
        Early fluid resuscitation in patients with rhabdomyolysis.
        Nat Rev Nephrol. 2011 May 17; 7: 416-422
        • Nance J.R.
        • Mammen A.L.
        Diagnostic evaluation of rhabdomyolysis.
        Muscle Nerve. 2015 Jun; 51: 793-810
        • Chen C.Y.
        • Lin Y.R.
        • Zhao L.L.
        • et al.
        Clinical spectrum of rhabdomyolysis presented to pediatric emergency department.
        BMC Pediatr. 2013; 13: 134
        • Bagley W.H.
        • Yang H.
        • Shah K.H.
        Rhabdomyolysis.
        Intern Emerg Med. 2007 Oct; 2: 210-218
        • Cervellin G.
        • Comelli I.
        • Benatti M.
        • et al.
        Non-traumatic rhabdomyolysis: background, laboratory features, and acute clinical management.
        Clin Biochem. 2017 Aug; 50: 656-662
        • Safari S.
        • Yousefifard M.
        • Hashemi B.
        • et al.
        The value of serum creatine kinase in predicting the risk of rhabdomyolysis-induced acute kidney injury: a systematic review and meta-analysis.
        Clin Exp Nephrol. 2016 Apr; 20: 153-161
        • Rodríguez-Capote K.
        • Balion C.M.
        • Hill S.A.
        • et al.
        Utility of urine myoglobin for the prediction of acute renal failure in patients with suspected rhabdomyolysis: a systematic review.
        Clin Chem. 2009 Dec; 55: 2190-2197
        • Alhadi S.A.
        • Ruegner R.
        • Snowden B.
        • Hendey G.W.
        Urinalysis is an inadequate screen for rhabdomyolysis.
        Am J Emerg Med. 2014 Mar; 32: 260-262
        • David W.S.
        Myoglobinuria.
        Neurol Clin. 2000 Feb; 18: 215-243
        • Vanholder R.
        • Sever M.S.
        • Erek E.
        • Lameire N.
        Rhabdomyolysis.
        J Am Soc Nephrol. 2000 Aug; 11: 1553-1561
        • Wu A.H.
        • Laios I.
        • Green S.
        • et al.
        Immunoassays for serum and urine myoglobin: myoglobin clearance assessed as a risk factor for acute renal failure.
        Clin Chem. 1994; 40: 796-802
        • Scharman E.J.
        • Troutman W.G.
        Prevention of kidney injury following rhabdomyolysis: a systematic review.
        Ann Pharmacother. 2013 Jan; 47: 90-105
        • Cho Y.S.
        • Lim H.
        • Kim S.H.
        Comparison of lactated Ringer's solution and 0.9% saline in the treatment of rhabdomyolysis induced by doxylamine intoxication.
        Emerg Med J. 2007; 24: 276-280
        • Bragadottir G.
        • Redfors B.
        • Ricksten S.E.
        Mannitol increases renal blood flow and maintains filtration fraction and oxygenation in postoperative acute kidney injury: a prospective interventional study.
        Crit Care. 2012 Aug 17; 16: R159
        • Odeh M.
        The role of reperfusion-induced injury in the pathogenesis of the crush syndrome.
        N Engl J Med. 1991 May 16; 324: 1417-1422
        • Homsi E.
        • Barreiro M.F.
        • Orlando J.M.
        • Higa E.M.
        Prophylaxis of acute renal failure in patients with rhabdomyolysis.
        Ren Fail. 1997 Mar; 19: 283-288
        • Karajala V.
        • Mansour W.
        • Kellum J.A.
        Diuretics in acute kidney injury.
        Minerva Anestesiol. 2009; 75: 251-257
        • Vangstad M.
        • Bjornaas M.A.
        • Jacobsen D.
        Rhabdomyolysis: a 10-year retrospective study of patients treated in a medical department.
        Eur J Emerg Med. 2017 Oct 24; ([Epub ahead of print])https://doi.org/10.1097/MEJ.0000000000000510
        • McMahon G.M.
        • Zeng X.
        • Waikar S.S.
        A risk prediction score for kidney failure or mortality in rhabdomyolysis.
        JAMA Intern Med. 2013 Oct 28; 173: 1821-1828
        • Baldwin I.
        • Naka T.
        • Koch B.
        • Fealy N.
        • Bellomo R.
        A pilot randomised controlled comparison of continuous venovenous haemofiltration and extended daily dialysis with filtration: effect on small solutes and acid-base balance.
        Intensive Care Med. 2007; 33: 830-835
        • Zeng X.
        • Zhange L.
        • Wu T.
        • et al.
        Continuous renal replacement therapy (CRRT) for rhabdomyolysis.
        Cochrane Database Syst Rev. 2014; CD008566
        • Oh R.C.
        • Arter J.L.
        • Tiglao S.M.
        • et al.
        Exertional rhabdomyolysis: a case series of 30 hospitalized patients.
        Mil Med. 2015 Feb; 180: 201-207
        • Scalco R.S.
        • Snoeck M.
        • Quinlivan R.
        • et al.
        Exertional rhabdomyolysis: physiological response or manifestation of any underlying myopathy?.
        BMJ Open Sport Exerc Med. 2016 Sep 7; 2e000151
        • Kenney K.
        • Landau M.E.
        • Gonzalez R.S.
        • et al.
        Serum creatine kinase after exercise: drawing the line between physiological response and exertional rhabdomyolysis.
        Muscle Nerve. 2012 Mar; 45: 356-362
        • Clarkson P.M.
        • Kearns A.K.
        • Rouzier P.
        • et al.
        Serum creatine kinase levels and renal function measures in exertional muscle damage.
        Med Sci Sports Exerc. 2006 Apr; 38: 623-627
        • Delaney K.
        • Vohra R.
        Prediction of safe discharge of emergency department patients with acute rhabdomyolysis.
        Crit Care. 2004; 8: P154
        • Najafi I.
        • van Biesen W.
        • Sharifi A.
        • et al.
        Early detection of patients at high risk for acute kidney injury during disasters: development of a scoring system based on the Bam earthquake experience.
        J Nephrol. 2008; 21: 776-782
        • Paul A.
        • John B.
        • Pawar B.
        • Sadiq S.
        Renal profile in patients with orthopaedic trauma: a prospective study.
        Acta Orthop Belg. 2009; 75: 528-532

      CHORUS Manuscript

      View Open Manuscript

      Advertisement